نتایج جستجو برای: boost vaccination

تعداد نتایج: 84560  

Journal: :The Journal of infectious diseases 2014
Guiqin Wang Fan Zhou Philippe Buchy Teng Zuo Hongxing Hu Jingjing Liu Yufeng Song Heng Ding Cheguo Tsai Ze Chen Linqi Zhang Vincent Deubel Paul Zhou

Since 1996, highly pathogenic avian influenza (HPAI) H5N1 virus has presented a persistent threat to public health. Its high degree of genetic diversity also poses enormous challenges in developing effective vaccines. To search for vaccine regimens that could elicit broadly neutralizing antibody responses against diverse HPAI H5N1 strains, in the present study we tested H5 hemagglutinin (HA) fr...

Journal: :Methods 2003
Nicole A Doria-Rose Nancy L Haigwood

DNA vaccine strategies can differ greatly, with significant effects on the outcome of immunization. In this article, we discuss plasmid design strategies and vaccine regimens. Effectiveness against a pathogen can be affected by the choice of antigen and inclusion of multiple antigens. Gene expression and the resulting immune response can be improved by gene modification and choice of promoters....

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2005
Daniel P Webster Susanna Dunachie Jenni M Vuola Tamara Berthoud Sheila Keating Stephen M Laidlaw Samuel J McConkey Ian Poulton Laura Andrews Rikke F Andersen Philip Bejon Geoff Butcher Robert Sinden Michael A Skinner Sarah C Gilbert Adrian V S Hill

Malaria is a major global health problem for which an effective vaccine is required urgently. Prime-boost vaccination regimes involving plasmid DNA and recombinant modified vaccinia virus Ankara-encoding liver-stage malaria antigens have been shown to be powerfully immunogenic for T cells and capable of inducing partial protection against experimental malaria challenge in humans, manifested as ...

2013
Francisco de la Poza Eva Calvo-Pinilla Elena López-Gil Alejandro Marín-López Francisco Mateos Javier Castillo-Olivares Gema Lorenzo Javier Ortego

African horse sickness virus (AHSV) belongs to the genus Orbivirus. We have now engineered naked DNAs and recombinant modified vaccinia virus Ankara (rMVA) expressing VP2 and NS1 proteins from AHSV-4. IFNAR((-/-)) mice inoculated with DNA/rMVA-VP2,-NS1 from AHSV-4 in an heterologous prime-boost vaccination strategy generated significant levels of neutralizing antibodies specific of AHSV-4. In a...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2010
Godwin Nchinda David Amadu Christine Trumpfheller Olga Mizenina Klaus Uberla Ralph M Steinman

To improve the efficacy of T cell-based vaccination, we pursued the principle that CD4(+) T cells provide help for functional CD8(+) T cell immunity. To do so, we administered HIV gag to mice successively as protein and DNA vaccines. To achieve strong CD4(+) T cell immunity, the protein vaccine was targeted selectively to DEC-205, a receptor for antigen presentation on dendritic cells. This tar...

Journal: :Veterinary research 2003
Céline Héchard Olivier Grépinet Annie Rodolakis

In order to enhance the quantity and the protective properties of the antibodies induced by DNA vaccination with the heat shock protein dnaK gene of Chlamydophila abortus AB7 as well as to elicit an efficient cellular immune response, we vaccinated mice with a DNA prime followed by a boost with the recombinant DnaK protein. In non-pregnant mice, this strategy induced the same predominance of th...

Journal: :PLoS Neglected Tropical Diseases 2008
Audrey Tanghe Jean-Pierre Dangy Gerd Pluschke Kris Huygen

Vaccination with plasmid DNA encoding Ag85A from M. bovis BCG can partially protect C57BL/6 mice against a subsequent footpad challenge with M. ulcerans. Unfortunately, this cross-reactive protection is insufficient to completely control the infection. Although genes encoding Ag85A from M. bovis BCG (identical to genes from M. tuberculosis) and from M. ulcerans are highly conserved, minor seque...

2015
Christoph Jindra Bettina Huber Saeed Shafti-Keramat Markus Wolschek Boris Ferko Thomas Muster Sabine Brandt Reinhard Kirnbauer Sang-Moo Kang

Persistent infection with high-risk human papillomavirus (HPV) types, most often HPV16 and HPV18, causes all cervical and most anal cancers, and a subset of vulvar, vaginal, penile and oropharyngeal carcinomas. Two prophylactic virus-like particle (VLPs)-based vaccines, are available that protect against vaccine type-associated persistent infection and associated disease, yet have no therapeuti...

Journal: :The Journal of Experimental Medicine 2007
Wolfgang Kastenmuller Georg Gasteiger Julian H. Gronau Robert Baier Ronny Ljapoci Dirk H. Busch Ingo Drexler

CD8+ T cell responses directed against multiple pathogen-derived epitopes are characterized by defined immunodominance hierarchy patterns. A possible explanation for this phenomenon is that CD8+ T cells of different specificities compete for access to epitopes on antigen-presenting cells, and that the outcome of this so-called cross-competition reflects the number of induced T cells. In our stu...

Journal: :The Journal of infectious diseases 2010
Hannah Kibuuka Robert Kimutai Leonard Maboko Fred Sawe Mirjam S Schunk Arne Kroidl Douglas Shaffer Leigh Anne Eller Rukia Kibaya Michael A Eller Karin B Schindler Alexandra Schuetz Monica Millard Jason Kroll Len Dally Michael Hoelscher Robert Bailer Josephine H Cox Mary Marovich Deborah L Birx Barney S Graham Nelson L Michael Mark S de Souza Merlin L Robb

BACKGROUND Human immunodeficiency virus (HIV) vaccine development remains a global priority. We describe the safety and immunogenicity of a multiclade DNA vaccine prime with a replication-defective recombinant adenovirus serotype 5 (rAd5) boost. METHODS The vaccine is a 6-plasmid mixture encoding HIV envelope (env) subtypes A, B, and C and subtype B gag, pol, and nef, and an rAd5 expressing i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید